Principal Investigator
David Baidal
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20180480
Clinical Trial Summary
HYDROXYCHLOROQUINE FOR PREVENTION OF ABNORMAL GLUCOSE TOLERANCE AND DIABETES IN INDIVIDUALS AT-RISK FOR TYPE 1 DIABETES MELLITUS
Phase
Phase II
Funding Agency/Sponsor
Other
Disease
Other